... for estrogen receptor, progesterone receptor, and HER2. HER2-positive MBC is therefore extremely rare. Most MBCs have poor response to chemotherapy. HER2-targeted neoadjuvant chemotherapy (NAC) is widely performed and has high efficacy in treating HER2-positive breast cancer. We report an atypical case of HER2...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Atezolizumab Breast cancer Cystoid macular edema Nanoparticle albumin-bound paclitaxel Recently...

... of many different cancer types, but its combination with other anti-cancer therapy is not well understood. We report a case of a 66-year-old woman who presented with triple-negative breast cancer, multifocal hormone receptor-positive breast cancer, primary epidermal growth factor receptor-mutated lung...

...Yujing J. Heng; Kevin J. Zhang; Monica G. Valero; Gabrielle M. Baker; Valerie J. Fein-Zachary; Michael S. Irwig; Gerburg M. Wulf There is limited literature about breast cancer in the transgender population. Very little is known about how gender-affirming hormone therapy affects their breast cancer...

...Maho Sugino; Yoshiya Horimoto; Fumi Murakami; Yuka Takahashi; Kazutomo Ouchi; Hideaki Sato; Yasunori Ishido Encapsulated papillary carcinoma (EPC) is a relatively rare histologic type of breast cancer. It is sometimes difficult to obtain a definitive diagnosis by needle biopsy, reflecting its...

...Sherif Mostafa; Mhd Baraa Habib; Nada Ahmed; Bisher Sawaf; Nagham Sadik; Ahmed M. Abdalhadi Breast cancer is the most prevalent cancer in women worldwide, and its prevalence has increased since the introduction of screening programs. Most cases are discovered at an early stage; however, despite...

...Toko Kumeta; Kei Yamaguchi; Ryosuke Hayami; Kazumori Arai; Michiko Tsuneizumi; Ryoichi Matsunuma Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with higher rates of relapse and mortality compared to other subtypes. Chemotherapy has been a mainstream...

...Chiaki Matsui; Nobuhiro Shibata; Chie Hirai; Manami Tada; Yuichiro Kikawa; Tomoharu Sugie In recent years, both the number of patients with breast cancer and those with associated brain metastases (BMs) have increased. Human epidermal growth factor receptor 2 (HER2)-positive breast cancer has...

...Erika Barbieri; Giulia Caraceni; Damiano Gentile; Francesca Gavazzi; Alessandro Zerbi; Corrado Tinterri Gastrointestinal tract breast cancer (BC) metastases represent a rare event and generally originate from the lobular subtype. Duodenal involvement was rarely described in previous case series...

...Miriam Hussein; Anders Bonde Jensen Chemotherapy is widely used in cancer treatment, and the drug Capecitabine is often used in treatment of breast cancer and usually well-tolerated. Toxicity from Capecitabine typically involves hand-foot syndrome, fatigue, nausea, reduced appetite, and diarrhea...

... to spread worldwide with the development of highly transmissible strains. Several guidelines addressing management of cancer patients during the COVID-19 pandemic have been published, primarily based upon expert opinion. The COVID-19 pandemic has affected all aspects of breast cancer care including...

... the human epidermal growth factor receptor type 2 (HER2)-positive breast cancer with no distant metastasis, anti-HER2 agents-containing chemotherapy brought about clinical complete response of the locally advanced breast cancer with a shrunken but still large skin defect. We, therefore, treated the patient...

...Shirley Cheng; Edward Tri Nguyen; Jami Aya Fukui Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. In clinical practice, the standard method to confirm metastatic disease and tailor treatment is to biopsy a metastatic...

...Zhi Xu; Jing Jing Yuan; Jie Jiang; Lei Ma Liver metastasis commonly occurs; however, the luminal-type liver metastasis rarely develops at the early stage of breast cancer, posing key challenges in screening patients, giving early targeted treatment, and providing an opportunity to prolong survival...

...Kayono Onishi; Rurina Watanuki; Takamichi Yokoe; Tsuguo Iwatani; Chisako Yamauchi; Tatsuya Onishi We present a case of two recurrences in the brachial lymph nodes after initial resection, which was performed for radical cure. A 66-year-old woman was diagnosed with left breast cancer T4bN3cM0 Stage...

...Koji Yasuda; Shoji Oura; Shinichiro Makimoto A 36-year-old unmarried woman had undergone nipple-preserving mastectomy and immediate breast reconstruction using extended latissimus dorsi muscle flap for her left breast cancer. During adjuvant endocrine therapy, the patient sometimes developed faint...

... also depicted three daughter nodules located medially to the main tumor in a linear fashion. Patient’s strong request for nipple preservation made us try to resect the breast cancer in a manner to possibly preserve the nipple-areolar complex. First, to resect the target four tumors, medial horizontal...

...Tsuyoshi Nakagawa; Kumiko Hayashi; Ayumi Ogawa; Goshi Oda; Iichiro Onishi; Masahide Yamamoto; Mio Mori; Tomoyuki Fujioka; Toshiaki Ishikawa; Kentaro Okamoto; Hiroyuki Uetake Bone marrow carcinomatosis (BMC) associated with breast cancer is a rare but often difficult-to-treat condition; we report...

...Shuhei Suzuki; Shoji Oura; Shinichiro Makimoto A 78-year-old obese woman with breast cancer underwent breast-conserving surgery and axillary lymph node dissection. Due to the prior exposure to long-term taxan chemotherapy for her recurrent gastric cancer, the patient did not undergo adjuvant...

... of breast cancer treatment. We present the case of a 76-year-old woman who had a recurrence of pemphigus vulgaris limited to the irradiation field after exposure to an adjuvant radiotherapy treatment for a bilateral triple-negative breast cancer. The onset was bilateral limited to the irradiation area...